There is no current national screening programme for prostate cancer; the committee that decides these things is looking into ...
Those looking for clearer guidance on the practical application of Art 3(a) are likely to be left disappointed by yesterday’s CJEU judgment in the Teva v Gilead SPC litigation. Those looking for ...
In a landmark decision, the Swiss Federal Supreme Court confirmed the validity of Gilead’s Truvada SPC and ruled that future SPCs for combination products must meet CJEU case law requirements The ...
Our study is focused on mistakes in combination antihypertensive therapy as one aspect of pseudoresistance. The aim of the study was to analyze the clinical use of combination antihypertensive therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results